Cargando…

Effect of Tetrabenazine on Motor Function in Patients with Huntington Disease

INTRODUCTION: Tetrabenazine (TBZ) reduces chorea related to Huntington disease (HD); however, it is uncertain whether this effect improves functionally relevant motor skills such as hand coordination and balance. The objective of this study was to provide pilot data regarding three motor function te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrara, Joseph M., Mostile, Giovanni, Hunter, Christine, Adam, Octavian R., Jankovic, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare Communications 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389035/ https://www.ncbi.nlm.nih.gov/pubmed/26000211 http://dx.doi.org/10.1007/s40120-012-0005-7

Ejemplares similares

Clinical Assessment of the Effect of Tetrabenazine on Functional Scales in Huntington Disease: A Pilot Open Label Study
por: Fekete, Robert, et al.
Publicado: (2012)

Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007)

Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington’s and Other Diseases
por: Shen, Vivienne, et al.
Publicado: (2013)

Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010)

Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011)

Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2017)

Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
por: Rodrigues, Filipe B., et al.
Publicado: (2017)

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
por: Frank, Samuel
Publicado: (2010)

Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
por: Frank, Samuel
Publicado: (2011)

Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
por: Dorsey, Ray, et al.
Publicado: (2011)

Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis
por: Claassen, Daniel O., et al.
Publicado: (2021)

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
por: Frank, Samuel
Publicado: (2009)

Meta-research metrics matter: letter regarding article “indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease”
por: Rodrigues, Filipe B., et al.
Publicado: (2017)

Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine
por: Sung, Victor W., et al.
Publicado: (2018)

Upper facial chorea in Huntington disease
por: Fekete, Robert, et al.
Publicado: (2014)

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect
por: Schneider, Frank, et al.
Publicado: (2020)

Structural Mechanisms for VMAT2 inhibition by tetrabenazine
por: Dalton, Michael P., et al.
Publicado: (2023)

Dual Treatment of Hemichorea–Hemiballismus Syndrome with Tetrabenazine and Chemodenervation
por: Umeh, Chizoba C., et al.
Publicado: (2012)

Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E
por: Sharma, Himanshu
Publicado: (2009)

Behaviour of Tetrabenazine in Acid Medium: Reassessment and Impact on Formulation
por: Ettouati, Laurent, et al.
Publicado: (2019)

Synthesis of Tetrabenazine and Its Derivatives, Pursuing Efficiency and Selectivity
por: Paek, Seung-Mann
Publicado: (2020)

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
por: Migliore, Simone, et al.
Publicado: (2019)

Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT
por: Ha, Ainhi D., et al.
Publicado: (2012)

Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine
por: Skor, Heather, et al.
Publicado: (2017)

Unique Case Reports of Tooth Sensitivity After Consuming Tetrabenazine
por: Daripa, Bob
Publicado: (2022)

Effective treatment of choreaballism due to an MT‐CYB variant with haloperidol, tetrabenazine, and antioxidants
por: Finsterer, Josef, et al.
Publicado: (2023)

Functional compensation of motor function in pre-symptomatic Huntington's disease
por: Klöppel, Stefan, et al.
Publicado: (2009)

Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Quadriparesis and dysarthria due to tetrabenazine therapy in a child with rheumatic chorea
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Enantioselective synthesis of (−)-tetrabenazine via continuous crystallization-induced diastereomer transformation
por: Kukor, Andrew J., et al.
Publicado: (2022)

A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine
por: Scalise, Roberta, et al.
Publicado: (2021)

A case of tics presenting as chronic intractable cough successfully treated with tetrabenazine
por: Pawar, Deepak G., et al.
Publicado: (2015)

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin
por: Aguilar, Lourdes, et al.
Publicado: (2019)

Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers
por: Schneider, Frank, et al.
Publicado: (2020)

PCR138 Association of SARS-CoV-2 Omicron Ba.1 on Adherence to Oral Tetrabenazine Congener and Quality of Life of Patients Diagnosed With Huntington's Disease With Chorea or Tardive Dyskinesia on the Service of a USA Specialty Pharmacy
por: Burruss, R, et al.
Publicado: (2022)

Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington’s Disease
por: Rao, Ashwini K., et al.
Publicado: (2011)

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Cerebellar degeneration correlates with motor symptoms in Huntington disease
por: Singh‐Bains, Malvindar K., et al.
Publicado: (2019)

DNA methylation study of Huntington’s disease and motor progression in patients and in animal models
por: Lu, Ake T., et al.
Publicado: (2020)

Preference for Exercise vs. More Sedentary Reinforcers: Validation of an Animal Model of Tetrabenazine-Induced Anergia
por: Carratalá-Ros, Carla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n8u6h90kjh37rkovfl272dqjhl